Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Integra Lifesciences Holdings (IART) Shares Outstanding (Weighted Average) (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Shares Outstanding (Weighted Average) for 17 consecutive years, with $76.7 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) changed 0.44% to $76.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $76.7 million through Dec 2025, changed 0.44% year-over-year, with the annual reading at $76.7 million for FY2025, 0.44% changed from the prior year.
  • Shares Outstanding (Weighted Average) hit $76.7 million in Q4 2025 for Integra Lifesciences Holdings, roughly flat from $76.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $84.8 million in Q3 2021 to a low of $76.5 million in Q1 2025.
  • Historically, Shares Outstanding (Weighted Average) has averaged $80.5 million across 5 years, with a median of $80.5 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): grew 0.51% in 2021 and later dropped 5.05% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $84.7 million in 2021, then decreased by 2.01% to $83.0 million in 2022, then dropped by 3.5% to $80.1 million in 2023, then fell by 3.84% to $77.0 million in 2024, then decreased by 0.44% to $76.7 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for IART at $76.7 million in Q4 2025, $76.8 million in Q3 2025, and $76.7 million in Q2 2025.